Homepage
Medication Guide
What Are the Purchase Channels for Sparsentan (Filspari)?
Sparsentan (Filspari) is a novel dual endothelin and angiotensin II receptor antagonist, which holds significant clinical value in delaying the decline of renal function in adult patients with primary...
502
Monday, December 1st, 2025, 11:36
Side Effects of Elacestrant (Orserdu)
Elacestrant (Orserdu) is an estrogen receptor antagonist, primarily indicated for the treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutat...
503
Monday, December 1st, 2025, 11:32
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)
Elacestrant (Orserdu) is an estrogen receptor antagonist, primarily indicated for the treatment of postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastati...
502
Monday, December 1st, 2025, 11:20
What Are the Indications of Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel estrogen receptor antagonist. It was approved for marketing by the U.S. FDA in 2023, providing a precise treatment option for patients with advanced breast cancer harb...
503
Monday, December 1st, 2025, 11:09
What Are the Purchase Channels for Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel estrogen receptor antagonist that plays an important role in the treatment of ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.What Are th...
502
Monday, December 1st, 2025, 10:45
Side Effects of Binimetinib (Mektovi)
Binimetinib (Mektovi) is a selective mitogen-activated protein kinase (MEK) inhibitor. It primarily blocks the RAS/RAF/MEK/ERK signaling pathway by inhibiting the activity of MEK1 and MEK2, thereby su...
502
Monday, December 1st, 2025, 10:42
What Are the Precautions for Binimetinib (Mektovi) Use?
Binimetinib (Mektovi) is a MEK inhibitor, usually used in combination with encorafenib, for the treatment of unresectable or metastatic melanoma positive for BRAF V600E or V600K mutations, as well as ...
502
Monday, December 1st, 2025, 10:38
Dosage and Administration, Recommended Dose of Binimetinib (Mektovi)
Binimetinib (Mektovi) is a kinase inhibitor, usually used in combination with encorafenib, for the treatment of unresectable or metastatic melanoma positive for BRAF V600E or V600K mutations, as well ...
502
Monday, December 1st, 2025, 10:10
What Are the Purchase Channels for Binimetinib (Mektovi)?
Binimetinib (Mektovi) is an important MEK inhibitor that plays a key role in the treatment of melanoma and lung cancer. As this medication is a prescription drug and related to significant health and ...
502
Monday, December 1st, 2025, 09:55
What are the Indications of Binimetinib (Mektovi)?
Binimetinib (Mektovi) is a highly potent and selective mitogen-activated protein kinase (MEK) inhibitor that plays a crucial role in the field of cancer treatment. As a molecular targeted therapy drug...
502
Monday, December 1st, 2025, 09:44
17 / 184
1837 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved